Clinical Trials Browser

NIH × Leiomyosarcoma × Nivolumab × Clear all

NCT02428192 2025-02-25

Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma

Phase 2 Completed

20 enrolled 11 charts

Leiomyosarcoma